Drug Trial Radar · NCT07300969
A Study to Evaluate the Effectiveness of DT-101 in Patients With Depression
Last checked: Nov 19, 2026Latest source record: Oct 8, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Recruiting
Enrollment
300
Planned (sponsor's estimate)
Start
Dec 16, 2025
Primary completion
Aug 2027
Study completion Aug 2027
Sponsor
- Lead sponsor
- Draig Therapeutics LtdIndustry
- Sponsor type
- Industry
- First posted
- Dec 24, 2025
Design
- Study type
- Interventional
- Phase
- Phase 2
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Triple (care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years, up to 75 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
The goal of this clinical trial is to learn if DT-101 can treat depression in adults. The effect of DT-101 will be compared to placebo. Subjects will attend the clinic every couple of weeks complete general health checks and complete questionnaires.
Conditions
- Major Depressive Disorder (MDD)
Interventions
DT-101Drug
DT-101 A
DT-101Drug
DT-101 B
PlaceboDrug
Placebo
Primary outcomes
What the sponsor says the trial is designed to measure.
- Change from baseline in total Montgomery Åsberg depression rating scale (MADRS) score, at Day 42Time frame: from enrollment to day 42
Locations
43 sites in 5 countries. Site status is shown where the registry gives one.
Draig Clinical Site
Bentonville, Arkansas · Recruiting
Draig Clinical Site
Little Rock, Arkansas · Recruiting
Draig Clinical Site
Oceanside, California · Recruiting
Draig Clinical Site
San Diego, California · Recruiting
Draig Clinical Site
Torrance, California · Recruiting
Draig Clinical Site
Miami, Florida · Recruiting
Draig Clinical Site
New Port Richey, Florida · Terminated
Draig Clinical Site
Orlando, Florida · Recruiting
Draig Clinical Site
Atlanta, Georgia · Recruiting
Draig Clinical Site
Decatur, Georgia · Recruiting
Draig Clinical Site
Gaithersburg, Maryland · Recruiting
Draig Clinical Site
Watertown, Massachusetts · Recruiting
Draig Clinical Site
Flowood, Mississippi · Recruiting
Draig Clinical Site
Las Vegas, Nevada · Recruiting
Draig Clinical Site
Marlton, New Jersey · Recruiting
Draig Clinical Site
New York, New York · Recruiting
Draig Clinical Site
Media, Pennsylvania · Terminated
Draig Clinical Site
Austin, Texas · Recruiting
Draig Clinical Site
Austin, Texas · Recruiting
Draig Clinical Site
DeSoto, Texas · Recruiting
Draig Clinical Site
Richardson, Texas · Recruiting
Draig Clinical Site
Wichita Falls, Texas · Terminated
Draig Clinical Site
Bellevue, Washington · Recruiting
Draig Clinical Site
Kazanlak, Bulgaria · Recruiting
Draig Clinical Site
Plovdiv, Bulgaria · Recruiting
Draig Clinical Site
Sofia, Bulgaria · Recruiting
Draig Clinical Site
Sofia, Bulgaria · Recruiting
Draig Clinical Site
Sofia, Bulgaria · Recruiting
Draig Clinical Site
Sofia, Bulgaria · Recruiting
Draig Clinical Site
Vratsa, Bulgaria · Recruiting
Draig Clinical Site
Ostrava, Czechia · Recruiting
Draig Clinical Site
Prague, Czechia · Recruiting
Draig Clinical Site
Říčany, Czechia · Recruiting
Draig Clinical Site
Gdansk, Poland · Recruiting
Draig Clinical Site
Katowice, Poland · Recruiting
Draig Clinical Site
Poznan, Poland · Recruiting
Draig Clinical Site
Chester, United Kingdom · Recruiting
Draig Clinical Site
Eastbourne, United Kingdom · Recruiting
Draig Clinical Site
Glasgow, United Kingdom · Recruiting
Draig Clinical Site
London, United Kingdom · Recruiting
Showing 40 of 43 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.